西妥昔單抗聯合放射和化學療法治療晚期鼻咽癌患者的觀察與護理_《華西醫學》

作者：

陳萍 , 張慶 , 周俊 , 唐偉林 , 李莎莎 ,  胡義德

關鍵詞：

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： 陳萍,張慶,周俊,唐偉林,李莎莎,胡義德. 西妥昔單抗聯合放射和化學療法治療晚期鼻咽癌患者的觀察與護理. 華西醫學, 2011, 26(5): 798-. doi: 復制

1.	Tham I, Lu J. Controversies and challenges in the current management of nasopharyngeal cancer[J]. Expert Rev Anticancer Ther, 2010, 10(9): 1439-1450.
2.	Le Tourneau C, Siu L. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck[J]. Curr Opin Oncol, 2008, 20(3): 256-263.
3.	呂汪霞,馬勝林. 西妥昔單抗的臨床研究新進展[J]. 醫學綜述, 2010, 16(9): 1345-1348.
4.	Pryor D, Porceddu S, Burmeister B, et al. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer[J]. Radiother Oncol, 90(2): 172-176.
5.	Baselga J. The EGFR as a targe for anti-cancer therapy focus on cetuximab[J]. Eur J Cancer, 2001, 37(Suppl 4): 16-22.
6.	David E. Cetuximab in metastatic colorectal cancer[J]. London Cancer New Drugs Grorp-APC/DTC Briefing, 2005, 7(1): 1-10.

1. 　Tham I, Lu J. Controversies and challenges in the current management of nasopharyngeal cancer[J]. Expert Rev Anticancer Ther, 2010, 10(9): 1439-1450.
2. 　Le Tourneau C, Siu L. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck[J]. Curr Opin Oncol, 2008, 20(3): 256-263.
3. 　呂汪霞,馬勝林. 西妥昔單抗的臨床研究新進展[J]. 醫學綜述, 2010, 16(9): 1345-1348.
4. 　Pryor D, Porceddu S, Burmeister B, et al. Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer[J]. Radiother Oncol, 90(2): 172-176.
5. 　Baselga J. The EGFR as a targe for anti-cancer therapy focus on cetuximab[J]. Eur J Cancer, 2001, 37(Suppl 4): 16-22.
6. 　David E. Cetuximab in metastatic colorectal cancer[J]. London Cancer New Drugs Grorp-APC/DTC Briefing, 2005, 7(1): 1-10.